Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Synageva BioPharma Corp

+ Add to Watchlist


218.1100 USD 2.3200 1.08%

As of 20:10:00 ET on 05/22/2015.

Company Profile for Synageva BioPharma Corp (GEVA)

Synageva BioPharma Corp. is a clinical stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.

Contact Information

Synageva BioPharma Corp

128 Spring Street
Suite 520
Lexington, MA 02421
United States
Phone: 1-781-357-9900
Fax: 1-781-357-9901

Key Executives for Synageva BioPharma Corp (GEVA)

Sanj K PatelPresident/CEORobert Bazemore "Rob"Chief Operating Officer
Anthony G QuinnExec VP/Chief Medical OfficerCarsten BoessSenior VP/CFO
Glen WilliamsSenior VP:Global Technical OpsMatthew S OsborneVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil